Moderna Inc
MRNAHealthcare|Biotechnology|USA
$48.77
-0.43 (-0.87%)
DCF (FCF)
$77.19
Tangible Book
$21.71
About
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Stock Price
+89.5%(1Y)
Pipeline Summary
137 total trials59
Phase 1
52
Phase 2
28
Phase 3
5
Phase 4
Recruiting: 22Completed: 80Active: 24Terminated: 6Withdrawn: 4Unknown: 1
Active Trials (46)
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
NCT05668741Cystic Fibrosis
Phase 1Phase 2Recruiting
Enrollment: 39 participants
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
NCT06623422Carcinoma, Non-Small-Cell Lung
Phase 3Recruiting
Enrollment: 680 participants
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
NCT06735248Multiple Sclerosis
Phase 2Recruiting
Enrollment: 180 participants
A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk Adults
NCT06067230Respiratory Syncytial Virus
Phase 3Active
Enrollment: 1,153 participants
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
NCT07089706COVID-19
Phase 4Recruiting
Enrollment: 832 participants
BioScore
6.5/10
Buy
Ownership
Recent Insider Trades
Klinger Shannon ThymeSELL
2026-03-0213,885 shares @ $52.29
Hoge StephenSELL
2026-02-23160,009 shares @ $48.84
AFEYAN NOUBARSELL
2025-12-1123,853 shares @ $29.49
Hussain AbbasSELL
2025-12-09504 shares @ $27.6
Hussain AbbasSELL
2025-06-11312 shares @ $28
Recent News
2026-04-07 00:00:03
2026-04-02 14:03:01
2026-03-31 18:25:34
2026-03-19 07:34:01
2026-03-18 18:51:19
Data last updated: Apr 7, 2026, 03:33 AM